Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hologic, Inc. (HOLX : NSDQ)
 
 • Company Description   
Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Number of Employees: 7,063

 
 • Price / Volume Information   
Yesterday's Closing Price: $74.23 Daily Weekly Monthly
20 Day Moving Average: 4,665,735 shares
Shares Outstanding: 222.42 (millions)
Market Capitalization: $16,510.18 (millions)
Beta: 0.65
52 Week High: $80.75
52 Week Low: $51.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.62% 7.94%
12 Week 7.61% 2.39%
Year To Date 2.97% -10.89%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
250 CAMPUS DRIVE
-
MARLBOROUGH,MA 01752
USA		 ph: 508-263-2900
fax: 781-890-8031		 michael.watts@hologic.com http://www.hologic.com
 
 • General Corporate Information   
Officers
STEPHEN P. MACMILLAN - Chief Executive Officer; Chairman and President
KARLEEN M. OBERTON - Chief Financial Officer
BENJAMIN J. COHN - Vice President and Corporate Controller
AMY M. WENDELL - Lead Independent Director
SALLY W. CRAWFORD - Director

Peer Information
Hologic, Inc. (ABMD)
Hologic, Inc. (DMDS)
Hologic, Inc. (CPWY.)
Hologic, Inc. (EQUR)
Hologic, Inc. (ECIA)
Hologic, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 436440101
SIC: 3844
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/04/26
Share - Related Items
Shares Outstanding: 222.42
Most Recent Split Date: 4.00 (2.00:1)
Beta: 0.65
Market Capitalization: $16,510.18 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.08 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.48 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 7.82% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.58
Trailing 12 Months: 17.38
PEG Ratio: 2.12
Price Ratios
Price/Book: 3.27
Price/Cash Flow: 13.00
Price / Sales: 4.03
EPS Growth
vs. Year Ago Period: 11.88%
vs. Previous Quarter: 4.63%
Sales Growth
vs. Year Ago Period: 6.24%
vs. Previous Quarter: 2.51%
ROE
09/30/25 - 20.13
06/30/25 - 19.69
03/31/25 - 19.71
ROA
09/30/25 - 11.06
06/30/25 - 10.82
03/31/25 - 10.87
Current Ratio
09/30/25 - 3.75
06/30/25 - 3.55
03/31/25 - 3.24
Quick Ratio
09/30/25 - -
06/30/25 - 2.81
03/31/25 - 2.52
Operating Margin
09/30/25 - 23.66
06/30/25 - 23.60
03/31/25 - 23.83
Net Margin
09/30/25 - 13.80
06/30/25 - 13.79
03/31/25 - 13.83
Pre-Tax Margin
09/30/25 - 16.61
06/30/25 - 16.73
03/31/25 - 16.92
Book Value
09/30/25 - 22.69
06/30/25 - 21.77
03/31/25 - 20.73
Inventory Turnover
09/30/25 - 2.82
06/30/25 - 2.76
03/31/25 - 2.82
Debt-to-Equity
09/30/25 - 0.50
06/30/25 - 0.52
03/31/25 - 0.54
Debt-to-Capital
09/30/25 - 33.17
06/30/25 - 34.22
03/31/25 - 34.86
 

Powered by Zacks Investment Research ©